Search Results 731-740 of 31181 for breast cancer
Sometimes calcifications indicate breast cancer, such as ductal carcinoma in situ (DCIS), but most calcifications result from noncancerous (benign) ...
— Mayo Clinic will host the Sixth Annual Metastatic Breast Cancer Conference at the Omni Scottsdale Resort and Spa at Montelucia in Scottsdale, Arizona, Sept.
The Biostatistics, Bioinformatics and Patient Registry Core provides expertise in biostatistics and bioinformatics for all Mayo Clinic Breast Cancer SPORE ...
Analyzing the genetic makeup of breast cancer cells to understand how DNA changes affect response to cancer treatments and personalize treatment options.
The purpose of this study is to develop a breast cancer survivor (BCS) multiscale omics database that includes a complete fecal metagenome (gut microbiome) and ...
It is not yet known whether combination chemotherapy is more effective with or without trastuzumab in treating breast cancer. Participation eligibility.
Success of cancer immunotherapy is limited by the ability of solid tumors to evade local and systemic antitumoral immune responses. Several mechanisms of tumor ...
PURPOSE: Phase II trial to study the effectiveness of combining paclitaxel, carboplatin, and trastuzumab in treating women who have metastatic breast cancer ...
While HER2-positive breast cancers tend to be more aggressive than other types of breast cancer, treatments that specifically target it are effective, and the ...
Viral Therapy In Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Cancer or Metastatic Breast Cancer. Print ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Thanks to generous benefactors, your gift today can have 5X the impact to advance AI innovation at Mayo Clinic.